Navigation Links
Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
Date:3/7/2008

ngs, interim results of preclinical or clinical studies do not necessarily predict their final results, and acceptable results in early studies might not be obtained in later studies. Drug candidates in the later stages of clinical development may fail to show the desired safety and efficacy traits despite positive results in initial clinical testing.

Additionally, as indicated in previous filings, there can be no assurance that the results from the Sulonex Phase 3 study will track the data from the pilot Collaborative Study Group Phase 2 study or the DiNAS Phase 2 study. Results from these earlier Sulonex studies may not be indicative of results from future clinical trials and the risk remains that the pivotal program for Sulonex may generate efficacy data that will be insufficient for the approval of the drug, or may raise safety concerns that may prevent approval of the drug.

Some of the statements included in this press release anticipating future clinical and business prospects for our lead drug candidate Sulonex, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward- looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: if, upon final analysis, it is determined that all trials of Sulonex should be terminated, our ability to successfully adjust our strategy and reduce our operating expenses in order to properly support the trials of our other drug candidates; if, upon final analysis of the Phase 3 data, it is determined that dosing should continue in the Phase 4 study, our ability to complete enrollment into the Phase 4 study on the timetable previously set for completion of Phase 4; our ability to complete cost- effective clinical trials or meet anticipated development timelines for the other drug candidates in our pi
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
8. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report of 68 pages with latest updates, ... library. The report "Pemphigus - Pipeline Review, H1 ... therapeutic development for Pemphigus , complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/31/2015)... N.C. , March 31, 2015  Dr. Renu ... be attending the World Orphan Drug Congress in April to ... regulatory approval process and orphan drugs below: ... has recommended to the Ministry of Health that if a ... marketing authorization can be obtained in India ...
(Date:3/31/2015)...   Halyard Health (NYSE: HYH ), ... a new purchasing agreement with HealthTrust for ... 2015, Halyard,s standard and ASTM-rated face masks , ... available to HealthTrust members made up of 1,350 acute ... physician practices and alternate care facilities. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3
(Date:4/1/2015)... When you’re suffering from back pain, the causes might ... the causes of lingering back or neck pain is important ... chronic back pain is due to facet joint syndrome, which ... pain and offers many possible treatments, according to Kaixuan ... Spine Center . , Dr. Liu clarifies the term “facet ...
(Date:4/1/2015)... On April 1st, 2015, Dr. Jason Helfrich, co-founder of ... TV to discuss the epidemic known as “Text Neck.” The average ... angle in which it is bent forward, such as when bent ... spine can cause poor posture often times leading to wear and ... spend hours on their cell phone device emailing, keeping up with ...
(Date:4/1/2015)... CT (PRWEB) April 01, 2015 Results ... Energy Challenge , which featured 11 new homes from ... construct residences that best utilized innovative building techniques and ... or net-zero. Steven Winter Associates, Inc. (SWA) provided sustainability ... into this year’s challenge, including the first- and third-place ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Continuing Education ... 6th Annual Essentials in Primary Care Summer CME Conference ... Island Golf Resort. The conference features an expert ... Essentials in Primary Care Summer Conference Session I ... therapeutic areas. The emphasis is on practical and useful information ...
(Date:4/1/2015)... Enterprise Integration has appeared on Penton ... list and report identifying the world’s top 501 ... is currently available on the MSPmentor. Additional lists ... in North America ,     The top MSPs ...     The top MSPs in Asia, Australia and New ...
Breaking Medicine News(10 mins):Health News:Demystifying Facet Joint Syndrome 2Health News:Demystifying Facet Joint Syndrome 3Health News:Demystifying Facet Joint Syndrome 4Health News:Dr. Jason Helfrich, Co-Founder of 100% Chiropractic, is a Guest on Better TV to Discuss “Text Neck” 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 2Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 3Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 4Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3
... ... style, mama, home, news, and food. Greenista.com,s daily emails to their reader,s inbox will keep ... New ... is a fashionista with a green conscience. Just in time for Earth Day’s 40th Anniversary, ...
... ... social bookmarking service is now redirected to its mother site, Psoop.com with more features. ... (PRWEB) March ... with content management features that will make social bookmarking and news posting easier and ...
... ... Surgery Studios and Candace Crowe Design has grown into a full-fledged partnership. Through synergized ... education through multimedia avenues. , ... (PRWEB) April 22, 2010 -- Plastic Surgery Studios, a total Internet ...
... ... WordStat 6, delivering enhanced analytical and visualization tools for textual data. This new version ... of phrases, new visualization and reporting tools as well as numerous speed optimizations and ... ...
... ... medical cannabis , ... (Vocus) April 22, 2010 -- MarijuanaDoctors.com, the nation’s leading online medical marijuana evaluations company, ... joined forces to help patients across the country find quality medical marijuana doctors ...
... Hawaii Instructors ... ... (ISR, www.infantswim.com ), the safest provider of Self-Rescue swimming lessons for babies and toddlers ... Oahu, including: Honolulu, Aiea, North Shore, Waipahu and Kailua. Since 2008, local ISR instructors have ...
Cached Medicine News:Health News:New Eco Site, Greenista.com, Launches on Earth Day 2Health News:GoldenBookmarks.com is Now Known as Psoop.com 2Health News:Plastic Surgery Studios and Candace Crowe Design Create New Partnership 2Health News:Provalis Research Announces the Release of WordStat 6, Delivering Enhanced Analytical and Visualization Tools for Textual Data 2Health News:MarijuanaDoctors.com and PotLocator.com Form Alliance, Expand Medical Marijuana iPhone App 2Health News:MarijuanaDoctors.com and PotLocator.com Form Alliance, Expand Medical Marijuana iPhone App 3Health News:Infant Swimming Resource Now Has 11 Self-RescueTM Swimming Locations in Hawaii 2Health News:Infant Swimming Resource Now Has 11 Self-RescueTM Swimming Locations in Hawaii 3
Enzyme immunoassay for the quantitative determination of Gliadin-IgG antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
... Free Estriol ELISA kit is used for ... human serum or plasma. This Free Estriol ... The samples, standards, and controls are incubated ... coated with anti-Estriol antibody. Free Estriol in ...
Medicine Products: